Basic Information About Buprenorphine

Basic Information About DATA

On October 17, 2000 Title XXXV of the Children’s Health Act of 2000 was enacted that permits the prescribing of schedule III, IV or V opioid treatment drugs that are approved by the FDA for maintenance or detoxification treatment.

Summary of Title XXXV

NIDA/SAMHSA Announcement & Press Release

NIDA Research and SAMHSA Physician Training Combine to Put Care for Opiate Dependence in Hands of Family Doctor. NIDA SAMHSA Press Release, October 9, 2002.

Federal Government Information

The SAMHSA, CSAT and FDA websites contains valuable information about Buprenorphine for physicians, patients and healthcare professionals that want to know more about buprenorphrine.

Find a Physician

CSAT’s Buprenorphrine Physician Locator

Guidelines	Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction, 2004. Chair McNicholas, L. Treatment Improvement Protocol, Number 40. DHHS Publication N0. (SMA) 04-3939.  , Order from NCADI or by calling 1-800-729-6686.
Patient Brochure	Introducing Office-Based Treatment for Opioid Addiction Order from NCADI or by calling 1-800-729-6686.

Publications

Office-Based Treatment of Opiate Addiction with a Sublingual-Tablet Formulation of Buprenorphine and Naloxone.
Comments by Andrew Byrne, September 23, 2003. (Published in NEJM (2003) 349:949-958).

Doctors Still Waiting to Test Buprenorphine’s Promise.
Join Together Online, January 21, 2003.

Buprenorphine treats opiate addiction in office; Two Sublingual Formulations Approved.
Mechcatie, E. Family Practice News November 15, 2002 32(22): 7.

Model Policy Guidelines for Opioid Addiction Treatment in the Medical Office . Federation of State Medical Boards (FSMB) of the United States. Adopted April 2002.
 

Using buprenorphine for office-based treatment of opioid addiction.
Recommendations to the Center of Substance Abuse Treatment (CSAT) of the Substance Abuse and Mental Health Services Administration (SAMHSA), from CSAT’s National Advisory Council. September 15, 1999.
 

Buprenorphine An Alternative Treatment for Opioid Dependence.
Blaine, J. (editor). NIDA Research Monograph 121. Rockville: DHHS, 1992.
 

Pain Management, November 22, 2004.
Reckitt Benckiser Form Letter.
 

New Paths to Recovery.
 New York City Forum, August 4, 2003.
(full transcript)
 

Buprenorphrine.
Kleber, H. Presented at New Paths to Recovery. New York: August 4, 2003.
 

Viewers and Readers

r>

	Windows Powerpoint
	Apple Powerpoint
	Adobe Reader Windows & Apple
	Windows Word Viewer
	Apple Word Viewer